NASDAQ:JBIO | Insider Transactions — Page 3 | Jade Biosciences, Inc.

JBIO Insider Transactions — Page 3

217 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–217; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Cormorant Asset Management, LPOther2021-07-02Purchase500,000.0$14.0
Chen BihuaOther2021-07-02Purchase500,000.0$14.0
Cormorant Global Healthcare Master Fund, LPOther2021-07-02Purchase500,000.0$14.0
Cormorant Private Healthcare Fund II, LPOther2021-07-02Purchase500,000.0$14.0
RA Capital Healthcare Fund LPDirector,TenPercentOwner2021-07-02Purchase2,785,714.0$14.0
RA CAPITAL MANAGEMENT, L.P.Director,TenPercentOwner2021-07-02Purchase2,785,714.0$14.0
Kolchinsky PeterDirector,TenPercentOwner2021-07-02Purchase2,785,714.0$14.0
Shah Rajeev M.Director,TenPercentOwner2021-07-02Purchase2,785,714.0$14.0
RA Capital Nexus Fund, L.P.Director2021-07-02Purchase2,785,714.0$14.0
HEALY JAMESTenPercentOwner2021-07-02Purchase357,142.0$14.0
Sofinnova Management X, L.L.C.TenPercentOwner2021-07-02Purchase357,142.0$14.0
Sofinnova Venture Partners X, L.P.TenPercentOwner2021-07-02Purchase357,142.0$14.0
Katabi MahaDirector,TenPercentOwner2021-07-02Purchase357,142.0$14.0
GRAYZEL DAVID S.Director2021-07-02Purchase535,714.0$14.0
Atlas Venture Fund XII, L.P.TenPercentOwner2021-07-02Purchase535,714.0$14.0
Atlas Venture Associates XII, LLCTenPercentOwner2021-07-02Purchase535,714.0$14.0
Atlas Venture Associates XII, L.P.TenPercentOwner2021-07-02Purchase535,714.0$14.0